DOCSLIB.ORG

Case Report Successful Treatment of Griscelli Syndrome with Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Case Report Successful Treatment of Griscelli Syndrome with Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation (2002) 29, 995–998 2002 Nature Publishing Group All rights reserved 0268–3369/02 $25.00 www.nature.com/bmt Case report Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation M Arico`1, M Zecca2, N Santoro3, D Caselli2, R Maccario2, C Danesino4, G de Saint Basile5 and F Locatelli2 1Onco Ematologia Pediatrica, Ospedale dei Bambini ‘G Di Cristina’, Palermo, Italy; 2Oncoematologia Pediatrica, IRCCS Policlinico San Matteo, Universita` di Pavia, Italy; 3Clinica Pediatrica, Universita` di Bari, Italy; 4Biologia Generale e Genetica Medica, Universita` di Pavia, Italy; and 5Institut National de la Sante et de la Recherche Medicale (INSERM) U429, Hopital Necker Enfants Malades, Paris, France Summary: show severe neurologic impairment, without apparent immune abnormalities.4 Griscelli syndrome (GS) is a rare autosomal recessive First reports of this new clinical entity, distinct from disorder, characterized by pigmentary dilution of the Chediak–Higashi syndrome (OMIM 214500) (CHS), were skin and hair and in most patients by abnormal regu- provided simultaneously in 1978 by Griscelli et al1 and by lation of the immune system, which results in a syn- Siccardi et al.2 drome of macrophage hyperactivation, known as hemo- In 1997 Pastural et al5 found a homozygous C2332T phagocytic lymophohistiocytosis (HLH). Allogeneic truncating mutation of the gene encoding myosin VA hematopoietic stem cell transplantation (HSCT) is the (MYO5A) in a Turkish girl with GS. Other mutations of the only curative treatment available for genetically same gene were reported in other cases. Recently, Pastural induced HLH. Few cases of successful HSCT from a et al6 presented evidence suggesting the existence of a compatible donor have been reported in children with second locus associated with Griscelli syndrome in the GS. We describe the first patient with GS cured with 15q21 region, which is located less than 7.3 cm from the an allograft from a compatible unrelated bone marrow MYO5A gene. Mutations in RAB27A were found in 16 donor. We used a novel preparative regimen consisting patients with GS.3 Unlike MYO5A, the GTP-binding pro- of busulfan, thiotepa and fludarabine. The demon- tein RAB27A is involved in the control of immune regu- strated curative effect of HSCT from an unrelated lation, and it seems to be a key effector of cytotoxic granule donor in a patient with genetically determined HLH exocytosis, a pathway essential for immune homeostasis. also supports the use of a systematic diagnostic All patients with RAB27A mutations, but none with the approach in these patients, in order to identify those MYO5A mutation, developed HLH. In addition, RAB27A- with a worse prognosis and needing an urgent allograft deficient T cells exhibited reduced cytotoxicity and cyto- in a timely manner. lytic granule exocytosis, whereas MYO5A-defective T cells Bone Marrow Transplantation (2002) 29, 995–998. DOI: did not. 10.1038/sj/bmt/1703567 As mentioned above, GS is a very rare disease, with Keywords: Griscelli syndrome; hemophagocytic lym- about 30 cases reported over the past 20 years;1–4,7–11 it is phohistiocytosis usually fatal within the first few years of life, due to HLH, which in most cases is triggered by common infections. We report a new case of GS in an Italian child cured after HSCT from a matched unrelated donor. Griscelli syndrome (GS) (OMIM 214450) is a rare autoso- mal recessive disorder that results in pigmentary dilution of the skin and hair, in the presence of large clumps of Case report pigment in hair shafts and an accumulation of melanosomes 1,2 in melanocytes. Most patients with this disorder also A male child was the only child born to healthy first cousins develop an uncontrolled T lymphocyte and macrophage from Southern Italy. The pregnancy was uneventful. Family activation syndrome, known as hemophagocytic syndrome, history failed to disclose any relevant medical problem. At or hemophagocytic lymophohistiocytosis (HLH), leading to the age of 5.5 months, the boy developed persistent fever. death in the absence of allogeneic hematopoietic stem cell When first seen at the age of 7 months, he had fever, 3 transplantation (HSCT). Early in life, some GS patients edema, hepatosplenomegaly and skin rash. His hairs and eyebrows were silvery-gray. Blood count showed leuko- 3 3 Correspondence: M Arico`, Onco Ematologia Pediatrica, Ospedale dei penia (2100/mm , neutrophils 260/mm ), anemia (8.5 g/dl), 3 Bambini ‘G Di Cristina’, Palermo, Italy thrombocytopenia (14 000/mm ); triglycerides were Received 5 November 2001; accepted 18 February 2002 363 mg/dl, fibrinogen 130 mg/dl, and ferritin 1040 ng/ml. MUD-BMT for Griscelli syndrome M Arico` et al 996 Serum immunoglobulins were as follows: IgG 480 mg/dl days and teicoplanin (10 mg/kg/day) for 12 days led to res- (n.v. 351–919), IgA 7 mg/dl (n.v. 10–85), IgM 50 mg/dl olution of the clinical symptoms and disappearance of the (n.v. 38–204). Bone marrow aspiration showed increased organism from blood and stool. numbers of monocytes with active erythrophagocytosis and Thirty months after HSCT, the patient is well, with com- no blast cells. Examination of the cerebro-spinal fluid plete donor chimerism and normal full blood cell counts; he (CSF) showed 17 cells/mm3 with no evidence of hemo- is not receiving any immune suppression and has recovered phagocytosis. On the basis of these findings, HLH was normal function of the immune system (see also Table 1 diagnosed. Natural killer (NK) activity was tested and for further details). found to be impaired, with 2%, 3% and 15% of lysis at the effector:target ratios of 10:1, 30:1, 100:1, respectively. The child was treated with dexamethasone, etoposide and Discussion cyclosporine, according to the HLH–94 study,12 with immediate response and stable disease control. A search for Differential diagnosis between the different subtypes of a suitable unrelated donor was started in the international HLH is crucial for appropriate and successful therapy. In registries of both bone marrow and cord blood donors. particular, prompt identification of genetic disorders lead- The possibilities of CHS and GS were considered. ing to HLH may confirm the indication for allogeneic Microscopic examination of the hairs showed unevenly HSCT as the only curative tool, while other less severe clustered pigment in the medulla, characteristic of GS. conditions should be identified as soon as possible in order Mutation analysis of the RAB27A gene showed a homo- to avoid potentially unnecessary and life-threatening treat- zygous six base pair deletion (del 510 AAGCC) confirming ments.13 Presence of silvery-gray hairs in patients with the diagnosis of GS. HLH should be considered a strong hallmark of CHS or At the age of 16 months, treatment according to HLH– GS. 94 was withdrawn and the child underwent HSCT from an Allogeneic HSCT is the only treatment proved to be unrelated bone marrow donor. Donor and recipient were potentially curative in genetically based HLH. We have found to be completely identical using a high-resolution been able to identify only five cases of GS in the literature allelic technique for both HLA class I and class II antigens. treated with allogeneic HSCT, all from a family donor Conditioning regimen before the allograft comprised busul- (Table 2).7,9,14 In 1990 Schneider et al9 reported one con- fan (16 mg/kg) from days Ϫ9toϪ6, thiotepa (10 mg/kg) sanguinous family in which four of seven children had GS. on day Ϫ5, and fludarabine (40 mg/m2/day) i.v. from days Three patients died before 20 months of age; in the fourth Ϫ4toϪ2. Graft-versus-host disease prophylaxis consisted sibling, allogeneic HSCT was performed at 4 months of of cyclosporine A, short-term methotrexate and anti-lym- age. Two years later, the patient remained in excellent phocyte globulin (ALG, 10 mg/kg/day from days Ϫ4to health. Ϫ2). The number of nucleated cells infused was 7.8 ϫ In their report in 1994, Klein et al7 included three chil- 108/kg of recipient body weight. Hematopoietic and lymph- dren with GS who were allografted. Two patients died dur- oid engraftment were documented by studying the genetic ing the immediate post-transplantation period of infectious polymorphism of variable number of tandem repeat short complications, but one patient was cured and at the time DNA sequences (VNTRs). of the report, the follow-up was 5 years. In 1999, Tezcan et Engraftment of donor cells was prompt. The child reco- al14 carried out an allogeneic HSCT from an HLA-identical vered an absolute neutrophil count more than 0.5 ϫ 109/l on sibling donor on a 4-year-old girl with GS who presented day +14 after transplantation, whereas platelet engraftment in accelerated phase with neurological manifestations. She (у20 ϫ 109/l) was observed on day +21. The post-trans- was treated with etoposide, methylprednisolone and intra- plant course was complicated by an episode of sepsis from thecal methotrexate for 8 weeks and underwent BMT after vancomycin-resistant Enterococcus faecium. Treatment receiving a conditioning regimen including ALG (rabbit, with quinupristin/dalfopristin (7.5 mg/kg every 8 h) for 22 10 mg/kg ϫ 5 days), busulfan and cyclophosphamide. Table 1 Natural killer cell activity and immunological evaluation of the patient before and after allografting Pre-transplant 6 months after 12 months after transplantation transplantation NK activity at a 10:1 2% 15% 16% effector:target ratio NK activity at a 30:1 3% 23% 22% effector:target ratio NK activity
Load more

Recommended publications
  • Exophilin-5 Regulates Allergic Airway Inflammation by Controlling IL-33–Mediated Th2 Responses
    The Journal of Clinical Investigation RESEARCH ARTICLE Exophilin-5 regulates allergic airway inflammation by controlling IL-33–mediated Th2 responses Katsuhide Okunishi,1 Hao Wang,1 Maho Suzukawa,2,3 Ray Ishizaki,1 Eri Kobayashi,1 Miho Kihara,4 Takaya Abe,4,5 Jun-ichi Miyazaki,6 Masafumi Horie,7 Akira Saito,7 Hirohisa Saito,8 Susumu Nakae,9 and Tetsuro Izumi1 1Laboratory of Molecular Endocrinology and Metabolism, Department of Molecular Medicine, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan. 2National Hospital Organization Tokyo National Hospital, Tokyo, Japan. 3Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan. 4Laboratory for Animal Resource Development and 5Genetic Engineering, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan. 6Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan. 7Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 8Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. 9Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. A common variant in the RAB27A gene in adults was recently found to be associated with the fractional exhaled nitric oxide level, a marker of eosinophilic airway inflammation. The small GTPase Rab27 is known to regulate intracellular vesicle traffic, although its role in allergic responses is unclear. We demonstrated that exophilin-5, a Rab27-binding protein, was predominantly expressed in both of the major IL-33 producers, lung epithelial cells, and the specialized IL-5 and IL-13 producers in the CD44hiCD62LloCXCR3lo pathogenic Th2 cell population in mice.
    [Show full text]
  • Rab27a and Rab27b Control Different Steps of the Exosome Secretion Pathway
    ARTICLES Rab27a and Rab27b control different steps of the exosome secretion pathway Matias Ostrowski1,2, Nuno B. Carmo3,12, Sophie Krumeich1,2,12, Isabelle Fanget10,12, Graça Raposo4,2, Ariel Savina1,2, Catarina F. Moita3, Kristine Schauer4,2, Alistair N. Hume5, Rui P. Freitas3, Bruno Goud4,2, Philippe Benaroch1,2, Nir Hacohen8,9, Mitsunori Fukuda11, Claire Desnos10, Miguel C. Seabra5,6,7, François Darchen10, Sebastian Amigorena1,2, Luis F. Moita3,13 and Clotilde Thery1,2,13 Exosomes are secreted membrane vesicles that share structural and biochemical characteristics with intraluminal vesicles of multivesicular endosomes (MVEs). Exosomes could be involved in intercellular communication and in the pathogenesis of infectious and degenerative diseases. The molecular mechanisms of exosome biogenesis and secretion are, however, poorly understood. Using an RNA interference (RNAi) screen, we identified five Rab GTPases that promote exosome secretion in HeLa cells. Among these, Rab27a and Rab27b were found to function in MVE docking at the plasma membrane. The size of MVEs was strongly increased by Rab27a silencing, whereas MVEs were redistributed towards the perinuclear region upon Rab27b silencing. Thus, the two Rab27 isoforms have different roles in the exosomal pathway. In addition, silencing two known Rab27 effectors, Slp4 (also known as SYTL4, synaptotagmin-like 4) and Slac2b (also known as EXPH5, exophilin 5), inhibited exosome secretion and phenocopied silencing of Rab27a and Rab27b, respectively. Our results therefore strengthen the link between MVEs and exosomes, and introduce ways of manipulating exosome secretion in vivo. Exosomes are membrane vesicles secreted into the extracellular space membrane of MVEs into the lumen of these endosomes14.
    [Show full text]
  • The Genetics of Intellectual Disability: Whole Exome Sequencing to Find Causative Variants in Severe Cases
    Master’s Project in Medicine No 4362 The Genetics of Intellectual Disability: whole exome sequencing to find causative variants in severe cases Student Winteler Florence Supervisor Prof. Reymond Alexandre, Ph.D. Center for Integrative Genomics, UNIL Co-Supervisor Gueneau Lucie, Ph.D. Center for Integrative Genomics, UNIL Expert Prof. Draganski Bogdan, Dr. méd Département des neurosciences cliniques, CHUV Lausanne, 25.11.2017 Abstract Intellectual disability (ID) affects 1-3% of the population. A genetic origin is estimated to account for about half of the currently undiagnosed cases, and despite recent successes in identifying some of the genes, it has been suggested that hundreds more genes remain to be identified. ID can be isolated or part of a more complex clinical picture –indeed other symptoms are often found in patients with severe genetic ID, such as developmental delay, organ malformations or seizures. In this project, we used whole exome sequencing (WES) to analyse the coding regions of the genes (exons) of patients with undiagnosed ID and that of their families. The variants called by our algorithm were then grossly sorted out using criteria such as frequency in the general population and predicted pathogenicity. A second round of selection was made by looking at the relevant literature about the function of the underlying genes and pathways involved. The selected variants were then Sanger-sequenced for confirmation. This strategy allowed us to find the causative variant and give a diagnosis to the first family we analysed, as the patient was carrying a mutation in the Methyl-CpG binding protein 2 gene (MECP2), already known to cause Rett syndrome.
    [Show full text]
  • RAB27A Promotes Melanoma Cell Invasion and Metastasis Via Regulation of Pro
    RAB27A promotes melanoma cell invasion and metastasis via regulation of pro- invasive exosomes Dajiang Guo1,2*, Goldie Y. L. Lui1,2*, Siew Li Lai1, James S. Wilmott2,3, Shweta Tikoo1,2, Louise A. Jackett2,3,4, Camelia Quek3, Darren L. Brown5, Danae M. Sharp1,2, Rain Y.Q. Kwan1,2, Diego Chacon6,7, Jason H. Wong7,8, Dominik Beck6,7, Michelle van Geldermalsen1,2, Jeff Holst1,2, John F. Thompson2,3,4, Graham J. Mann3,9, Richard A. Scolyer2,3,4, Jennifer L. Stow5, Wolfgang Weninger1,10,11#, Nikolas K. Haass1,10,12#, Kimberley A. Beaumont1,2# 1The Centenary Institute, The University of Sydney, Newtown, NSW, Australia; Article 2Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia; 3Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia; 4Royal Prince Alfred Hospital, Camperdown, NSW, Australia; 5The Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; 6Centre for Health Technologies and the School of Biomedical Engineering, University of Technology, Sydney, NSW, Australia; 7Adult Cancer Program, Lowy Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia; 8School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong; 9Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia; 10Discipline of Dermatology, The Accepted University of Sydney, Camperdown, NSW, Australia; 11Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; 12The University of This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.
    [Show full text]
  • Blueprint Genetics Comprehensive Immune and Cytopenia Panel
    Comprehensive Immune and Cytopenia Panel Test code: IM0901 Is a 642 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of an inborn error of immunity, such as, Primary Immunodeficiency, Bone Marrow Failure Syndrome, Dyskeratosis Congenita, Neutropenia, Thrombocytopenia, Hemophagocytic Lymphohistiocytosis, Autoinflammatory Disorders, Complement System Disorder, Leukemia, or Chronic Granulomatous Disease. This panel includes most genes from Primary Immunodeficiency, Severe Combined Immunodeficiency, Complement System Disorder, Bone Marrow Failure Syndrome, Hemophagocytic Lymphohistiocytosis, Congenital Neutropenia, Thrombocytopenia, Congenital Diarrhea, Chronic Granulomatous Disease, Diamond-Blackfan Anemia, Fanconi Anemia, Dyskeratosis Congenita, Autoinflammatory Syndrome, and Hereditary Leukemia Panels as well as many other genes associated with inborn errors of immunity. Please note that unlike our other panels, this panel is on our Whole Exome Sequencing platform and cannot be customized. Pricing may vary from our regular panel pricing. About immunodeficiency and cytopenia disorders There is an enormous amount of phenotypic overlap between immunological and hematological disorders, which makes it challenging to know which of these two systems is not functioning properly. Knowing the underlying genetic cause of a person’s clinical diagnosis, especially immunodeficiency, bone marrow failure, neutropenia, thrombocytopenia, autoinflammatory disease, or bone marrow failure can sometime
    [Show full text]
  • Download CGT Exome V2.0
    CGT Exome version 2.
    [Show full text]
  • Essential Role of Microphthalmia Transcription Factor for DNA Replication, Mitosis and Genomic Stability in Melanoma
    Oncogene (2011) 30, 2319–2332 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma T Strub1,4, S Giuliano2,4,TYe1, C Bonet2, C Keime1, D Kobi1, S Le Gras1, M Cormont3, R Ballotti2, C Bertolotto2 and I Davidson1 1Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire, CNRS, INSERM, Universite´ de Strasbourg, Illkirch, France; 2INSERM U895 Team 1 and Department of Dermatology, CHU Nice, France and 3INSERM U895 Team 7, Nice, France Malignant melanoma is an aggressive cancer known use of internal promoters (Steingrimsson, 2008). The for its notorious resistance to most current therapies. MITF-M isoform (hereafter designated simply as The basic helix-loop-helix microphthalmia transcription MITF) is the major form produced specifically in the factor (MITF) is the master regulator determining the melanocyte lineage from an intronic promoter (Goding, identity and properties of the melanocyte lineage, and is 2000b). MITF is essential for the survival of melano- regarded as a lineage-specific ‘oncogene’ that has a blasts and postnatal melanocytes (McGill et al., 2002; critical role in the pathogenesis of melanoma. MITF Hou and Pavan, 2008), in which it also controls the promotes melanoma cell proliferation, whereas sustained expression of genes required for the melanin synthesis supression of MITF expression leads to senescence. (Bertolotto et al., 1998). By combining chromatin immunoprecipitation coupled to In addition to regulating multiple aspects of normal high throughput sequencing (ChIP-seq) and RNA sequen- melanocyte function, MITF also has a critical role in cing analyses, we show that MITF directly regulates a melanoma, in which it is required for survival, and set of genes required for DNA replication, repair and controls the proliferation, invasive and metastatic mitosis.
    [Show full text]
  • A Mutation in Rab27a Causes the Vesicle Transport Defects Observed in Ashen Mice
    A mutation in Rab27a causes the vesicle transport defects observed in ashen mice Scott M. Wilson*, Richard Yip*, Deborah A. Swing*, T. Norene O’Sullivan*, Yuke Zhang†, Edward K. Novak†, Richard T. Swank†, Liane B. Russell‡, Neal G. Copeland*, and Nancy A. Jenkins*§ *Mouse Cancer Genetics Program, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702; †Department of Molecular and Cell Biology, Roswell Park Cancer Institute, Buffalo, NY 14263; and ‡Biology Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831 Contributed by Liane B. Russell, May 11, 2000 The dilute (d), leaden (ln), and ashen (ash) mutations provide a cells (9, 10). The absence of SER in spines probably disrupts unique model system for studying vesicle transport in mammals. the regulation of intracellular Ca2ϩ and postsynaptic signal All three mutations produce a lightened coat color because of transduction. defects in pigment granule transport. In addition, all three muta- A retroviral integration into the d gene in mice carrying the tions are suppressed by the semidominant dilute-suppressor (dsu), dilute-viral (dv) allele allowed the cloning of the d gene and the providing genetic evidence that these mutations function in the demonstration that d encodes an unconventional myosin heavy- same or overlapping transport pathways. Previous studies showed chain, myosin Va (MyoVa) (11, 12). MyoVa is expressed at high that d encodes a major vesicle transport motor, myosin-VA, which levels in nearly all tissues in the adult (12) and has the expected is mutated in Griscelli syndrome patients. Here, using positional structure for a member of this family—i.e., a globular head cloning and bacterial artificial chromosome rescue, we show that domain containing the ATP- and actin-binding sites, a ‘‘neck’’ ash encodes Rab27a.
    [Show full text]
  • Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement
    ORIGINAL RESEARCH published: 10 December 2020 doi: 10.3389/fimmu.2020.612977 Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement Yuta Ohishi 1, Sandra Ammann 2,3, Vahid Ziaee 4,5, Katharina Strege 3, Miriam Groß 2, Carla Vazquez Amos 3, Mohammad Shahrooei 6, Parisa Ashournia 7, Anahita Razaghian 7, Gillian M. Griffiths 3, Stephan Ehl 2, Mitsunori Fukuda 1* and Nima Parvaneh 7,8* 1 Laboratory of Membrane Trafficking Mechanisms, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Sendai, Japan, 2 Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany, 3 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom, 4 Department of Pediatrics, Tehran University of Medical Sciences (TUMS), Tehran, Iran, 5 Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran, 6 Laboratory of Clinical Bacteriology and Mycology, Department of Edited by: Microbiology and Immunology, KU Leuven, Leuven, Belgium, 7 Division of Allergy and Clinical Immunology, Department of Antonio Condino-Neto, Pediatrics, Tehran University of Medical Sciences (TUMS), Tehran, Iran, 8 Research Center for Immunodeficiencies, Tehran University of São Paulo, Brazil University of Medical Sciences (TUMS), Tehran, Iran Reviewed by: Alain Fischer, Griscelli syndrome type 2 (GS-2) is an inborn error of immunity characterized by partial Institut National de la Sante´ et de la Recherche Me´ dicale (INSERM), albinism and episodes of hemophagocytic lymphohistiocytosis (HLH). It is caused by France RAB27A mutations that encode RAB27A, a member of the Rab GTPase family.
    [Show full text]
  • Elucidation of Melanogenesis-Associated Signaling Pathways Regulated by Argan Press Cake in B16 Melanoma Cells
    nutrients Article Elucidation of Melanogenesis-Associated Signaling Pathways Regulated by Argan Press Cake in B16 Melanoma Cells Thouria Bourhim 1,‡ , Myra O. Villareal 2,3,‡ , Chemseddoha Gadhi 1,2,* and Hiroko Isoda 2,3,* 1 Faculty of Sciences Semlalia, Cadi Ayyad University, Avenue Prince Moulay Abdellah, B.P. 2390, Marrakesh 40000, Morocco; [email protected] 2 Alliance for Research on the Mediterranean and North Africa (ARENA), University of Tsukuba, Tennodai 1-1-1, Tsukuba 305-8572, Japan; [email protected] 3 Faculty of Life and Environmental Sciences, University of Tsukuba, Tennodai 1-1-1, Tsukuba 305-8572, Japan * Correspondence: [email protected] (C.G.); [email protected] (H.I.) ‡ These authors contributed equally to this work. Abstract: The beneficial effect on health of argan oil is recognized worldwide. We have previously reported that the cake that remains after argan oil extraction (argan press-cake or APC) inhibits melanogenesis in B16 melanoma cells in a time-dependent manner without cytotoxicity. In this study, the global gene expression profile of B16 melanoma cells treated with APC extract was determined in order to gain an understanding of the possible mechanisms of action of APC. The results suggest that APC extract inhibits melanin biosynthesis by down-regulating microphthalmia- associated transcription factor (Mitf ) and its downstream signaling pathway through JNK signaling activation, and the inhibition of Wnt/β-catenin and cAMP/PKA signaling pathways. APC extract also prevented the transport of melanosomes by down-regulating Rab27a expression. These results suggest that APC may be an important natural skin whitening product and pharmacological agent used for clinical treatment of pigmentary disorders.
    [Show full text]
  • Rab27a and Munc18 As Molecular Determinants of Snare- Mediated Vesicle Docking, Priming, and Fusion in Glucose Regulatory Tissues
    RAB27A AND MUNC18 AS MOLECULAR DETERMINANTS OF SNARE- MEDIATED VESICLE DOCKING, PRIMING, AND FUSION IN GLUCOSE REGULATORY TISSUES by Matthew J. Merrins A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Molecular and Integrative Physiology) in The University of Michigan 2008 Doctoral Committee: Professor Edward L. Stuenkel, Co-chair Associate Professor Richard M. Mortensen, Co-chair Professor John A. Williams Professor Robert T. Kennedy Assistant Professor Anatoli N. Lopatin TABLE OF CONTENTS LIST OF FIGURES iii ABSTRACT iv CHAPTER I. BACKGROUND 1 Introduction 1 Vesicle Fusion Machinery: SNARE proteins 8 Vesicle Docking and Priming Machinery: Role of Munc18 13 Vesicle Docking and Priming Machinery: Role of Rab27a 19 Statement of Hypothesis and Specific Aims 31 References 40 II. MUNC18C INTERACTION WITH SYNTAXIN4 MONOMERS AND SNARE COMPLEX INTERMEDIATES IN GLUT4 VESICLE TRAFFICKING 51 Abstract 51 Introduction 52 Experimental Procedures 55 Results 62 Discussion 73 Addendum: Molecular Characterization of Munc18 as a Syntaxin Chaperone 79 References 111 III. RAB27A-DEPENDENT ACTIONS ON VESICLE DOCKING AND PRIMING IN PANCREATIC β-CELLS 115 Abstract 115 Introduction 116 Experimental Procedures 118 Results 119 Discussion 128 References 143 IV. DISCUSSION 148 ii LIST OF FIGURES CHAPTER I: 1.1. Insulin signaling pathways regulating GLUT4 vesicle translocation. 34 1.2. Model of the neuronal SNARE core complex. 35 1.3. Comparison of Sec1/Munc18 (SM) protein crystal structures 36 1.4. Sites of Rab27a action within the pathways of glucose-stimulated insulin secretion in pancreatic β-cells. 37 1.5. Granule pools in the pancreatic β-cell 38 1.6.
    [Show full text]
  • Microphthalmia-Associated Transcription Factor (MITF) – from Waardenburg Syndrome Genetics to Melanoma Therapy
    Review article Microphthalmia-associated transcription factor (MITF) – from Waardenburg syndrome genetics to melanoma therapy Ivan Šamija, Josip Lukač, Zvonko Kusić Department of Oncology and Nuclear Medicine, Microphthalmia-associated transcription factor (MITF) was University Hospital “Sestre milosrdnice”, first discovered as protein coded by gene whose mutations Zagreb, Croatia are associated with Waardenburg syndrome. Later, MITF was shown to be key transcription factor regulating melanogen- esis. Further studies have shown that in addition to regulat- ing melanogenesis MITF also plays central role in regulation Corresponding author: of melanocyte development and survival. MITF gene is am- Ivan Šamija plified in a proportion of melanomas and ectopic MITF ex- Department of oncology and Nuclear Medicine pression can transform melanocytes so MITF can function University Hospital “Sestre milosrdnice” as melanoma “lineage survival” oncogene. Different studies Vinogradska cesta 29 have further revealed MITF’s important but complex role in 10000 Zagreb tumorigenesis and progression of melanoma. As expected Croatia from its important role in melanocytes and melanoma MITF [email protected] is intricately regulated on all the levels from transcription to Tel.: + 385 1 3787647 post-translational modifications. Although complex mecha- nisms of MITF functioning are still being revealed, MITF already has a valuable role in managing melanoma patients. Immunohistochemical analysis of MITF has shown both di- agnostic and prognostic value in patients with melanoma. MITF is also a valuable specific marker for detection of circu- lating melanoma cells by reverse-transcription – polymerase chain reaction. MITF has recently been investigated as a po- tential target for melanoma therapy. Key words: Microphthalmia-associated transcription fac- Received: 28 September 2010 tor, Melanoma, Melanocytes, Biological tumor markers, Accepted: 31 October 2010 Waardenburg’s syndrome.
    [Show full text]